Clinical Trial Update: Brilinta Clinical Experience Investigation

View source ↗

Summary

A completed clinical trial update for Brilinta (ticagrelor) investigating its experience in patients with acute coronary syndrome and a history of myocardial in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome, Old Myocardial Infarction | Status: COMPLETED